COVID-19 vaccine for adolescents with chronic disease or disabilities
Main Article Content
Keywords
COVID-19 vaccine, adolescents, disabilities, chronic disease
Abstract
Background: Indonesia has a relatively high number of COVID-19 cases and mortalities, including children and adolescents groups. Vaccination coverage for these groups is currently low, especially in the population of children with disabilities and special needs, due to the difficulty of assisting them. The objective of this study was to share the data on the COVID-19 vaccine for adolescents with chronic diseases or disabilities.
Methods: This descriptive study uses data collected from two hospitals in September 2021. We analyzed the patients' characteristics, age groups, diagnoses, comorbidities, and adverse events following immunization (AEFI) of the adolescents injected with the COVID-19 vaccine.
Results: From a total of 94 adolescents, 51 have disabilities, and 43 have chronic disease. Disabilities include children with special needs (54%), attention deficit and hyperactivity disorder (4%), autism (11%), cerebral palsy (4%), and Down syndrome (27%). The accompanying chronic diseases vary widely, such as diabetes mellitus (28%), asthma (14%), rheumatic heart disease (14%) and thalassemia (14%). There were 6 patients found to have AEFI. Three of them have diabetes mellitus, the other two patients have thalassemia, and the other one patient has Down syndrome. Varies AEFIs were found, including fever, drowsiness, weakness, dizziness, hunger, and itching. All symptoms were improved within hours and did not require hospitalization.
Conclusion: Adolescents with disabilities and chronic diseases require special assistance and extra care during vaccination. The COVID-19 vaccine is relatively safe for adolescents in these groups without significant side effects.
References
2. Satuan Tugas Penanganan COVID-19. Peta Sebaran [Internet]. 2020. Available from: https://covid19.go.id/peta-sebaran
3. Nurbaiti A, Syakriah A. Indonesia reports higher COVID-19 death rate among children than United States [Internet]. The Jakarta Post. 2020. Available from: https://www.thejakartapost.com/news/2020/09/03/indonesia-reports-higher-covid-19-death-rate-among-children-than-united-states.html
4. Ikatan Dokter Anak Indonesia. Rekomendasi Ikatan Dokter Anak Indonesia Terkait Pemberian Vaksin COVID-19 pada Anak dan Remaja [Internet]. 2021. Available from: https://www.idai.or.id/tentang-idai/pernyataan-idai/rekomendasi-ikatan-dokter-anak-indonesia-terkait-pemberian-vaksin-covid-19-pada-anak-dan-remaja
5. World Health Organization. COVID-19 Vaccines: Monitoring and responding to adverse events following immunization (AEFIS) [Internet]. Geneva: World Health Organization; 2020. Available from: https://www.who.int/docs/default-source/covid-19-vaccines-safety-surveillance-manual/covid19vaccines_manual_aefi_20210104.pdf
6. Viner RM, Mytton OT, Bonell C, Melendez-Torres GJ, Ward J, Hudson L, et al. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults. JAMA Pediatr. 2021;175(2):143.
7. Tezer H, Bedir Demirdag T. Novel coronavirus disease (COVID-19) in children. Turk J Med Sci. 2020;50(SI-1):592–603.
8. Kim L, Whitaker M, O’Halloran A, Kambhampati A, Chai SJ, Reingold A, et al. Hospitalization Rates and Characteristics of Children Aged <18 Years Hospitalized with Laboratory-Confirmed COVID-19 - COVID-NET, 14 States, March 1-July 25, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(32):1081–8.
9. Mehta N, Mytton O, Mullins E, Fowler T, Falconer C, Murphy O, et al. SARS-CoV-2 (COVID-19): What Do We Know About Children? A Systematic Review. SSRN Electronic Journal. 2020;
10. Lee B, Raszka W V. COVID-19 Transmission and Children: The Child Is Not to Blame. Pediatrics. 2020;146(2).
11. Vogel L. Have we misjudged the role of children in spreading COVID-19? Can Med Assoc J. 2020;192(38):E1102–3.
12. Giubilini A, Savulescu J, Wilkinson D. COVID-19 vaccine: vaccinate the young to protect the old? J Law Biosci. 2020;7(1).
13. Huss G, Magendie C, Pettoello-Mantovani M, Jaeger-Roman E. Implications of the COVID-19 Pandemic for Pediatric Primary Care Practice in Europe. J Pediatr. 2021;233:290-291.e2.
14. Satuan Tugas Penanganan COVID-19. Peta Sebaran COVID-19 [Internet]. 2020. Available from: https://covid19.go.id/peta-sebaran
15. Kementerian Kesehatan Republik Indonesia. Cakupan Vaksinasi COVID-19 Capai 15,1 Juta Dosis [Internet]. Kementerian Kesehatan Republik Indonesia. 2021. Available from: https://www.kemkes.go.id/eng/rilis-kesehatan/cakupan-vaksinasi-covid-19-capai-151-juta-dosis
16. Kementerian Kesehatan Republik Indonesia. Profil Kesehatan Indonesia Tahun 2019. Jakarta: Kementerian Kesehatan Republik Indonesia; 2020.
17. Zablotsky B, Black LI, Maenner MJ, Schieve LA, Danielson ML, Bitsko RH, et al. Prevalence and Trends of Developmental Disabilities among Children in the United States: 2009–2017. Pediatrics. 2019;144(4).
18. Turk MA, Landes SD, Formica MK, Goss KD. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis. Disabil Health J. 2020;13(3):100942.
19. Centers for Disease Control and Prevention. People with Disabilities [Internet]. Centers for Disease Control and Prevention. 2021. Available from: https://www.cdc.gov/ncbddd/humandevelopment/covid-19/people-with-disabilities.html
20. FAIR Health. Risk factors for COVID-19 mortality among privately insured patients: a claims data analysis. New York: FAIR Health, Inc; 2020.
21. Kompaniyets L, Agathis NT, Nelson JM, Preston LE, Ko JY, Belay B, et al. Underlying Medical Conditions Associated With Severe COVID-19 Illness Among Children. JAMA Netw Open. 2021;4(6):e2111182.
22. Smith M, Peacock G, Uyeki TM, Moore C. Influenza vaccination in children with neurologic or neurodevelopmental disorders. Vaccine. 2015;33(20):2322–7.
23. Centers for Disease Control and Prevention. Influenza Vaccination Practices of Physicians and Caregivers of Children with Neurologic and Neurodevelopmental Conditions – U.S., 2011-12 [Internet]. Centers for Disease Control and Prevention. 2013. Available from: https://www.cdc.gov/ncbddd/developmentaldisabilities/features/keyfinding-flu-vaccine-neurologic.html